DGAP-Adhoc: Hapag-Lloyd AG publishes preliminary earnings figures for the first nine months of 2021 and raises its earnings outlook for the current financial year
2021. október 29., péntek, 15:51
DGAP-Ad-hoc: Hapag-Lloyd AG / Key word(s): Change in Forecast/Preliminary Results Hapag-Lloyd AG publishes preliminary earnings figures for the first nine months of 2021 and raises its earnings outlook for the current financial year Based on preliminary figures, EBITDA for the first nine months of 2021 is anticipated to be in the range of EUR 6.8 billion compared to around EUR 1.8 billion in the prior-year period. At the same time, EBIT is expected to be roughly EUR 5.8 billion compared to approximately EUR 0.9 billion in the first nine months of 2020. Given the earnings momentum is likely to remain on a high level, the Executive Board of Hapag-Lloyd AG has decided today to raise its earnings outlook. 2021 Group EBITDA is now expected to be in the range of EUR 10.1 - 10.9 billion (previously: EUR 7.6 - 9.3 billion) and Group EBIT in the range of EUR 8.7 - 9.5 billion (previously: EUR 6.2 - 7.9 billion). The final business figures for the first nine months of 2021 will be published as planned on 12 November 2021. Explanatory notes relating to the performance measures EBITDA and EBIT referred to herein can be found in the 2020 Annual Report:
2021 EARNINGS OUTLOOK*
* Figures rounded.
Heiko Hoffmann Senior Director Investor Relations Hapag-Lloyd AG Ballindamm 25 20095 Hamburg Phone +49 40 3001-2896 Fax +49 40 3001-72896 Mobile +49 172 875-2126
|
Language: | English |
Company: | Hapag-Lloyd AG |
Ballindamm 25 | |
20095 Hamburg | |
Germany | |
Phone: | +49 (0) 40 3001 - 2896 |
Fax: | +49 (0) 40 3001 - 72896 |
E-mail: | ir@hlag.com |
Internet: | www.hapag-lloyd.com |
ISIN: | DE000HLAG475 |
WKN: | HLAG47 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1244895 |
End of Announcement | DGAP News Service |
1244895 29-Oct-2021 CET/CEST
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]